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Mutations of the human HSF4 gene have been implicated in congenital and age-related cataracts. Here, we
show that HSF4 activates transcription of genes encoding crystallins and beaded ﬁlament structural proteins
in lens epithelial cells. Five missense mutations that have been associated with congenital cataract inhibited
DNA-binding of HSF4, which demonstrates the relationship between HSF4 mutations, loss of lens protein
gene expression, and cataractogenesis. However, two missense mutations that have been associated with
age-related cataract did not or only slightly alter HSF4 activity, implying that other genetic and
environmental factors affect the functions of these mutant proteins.+81 76 234 4369.
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Cataracts are deﬁned as lens opacities. Cataractogenesis has
multiple causes and is often associated with a breakdown of the
lens microarchitecture [1]. Lens proteins undergo a wide variety of
alterations with age, and many of these are accelerated by oxidative,
osmotic, and other stresses. In addition to environmental risk factors,
genetic factors are also important in age-related cataract formation
[2,3]. Congenital cataract is likely to cause childhood blindness. It is
known that mutations in genes encoding two groups of proteins cause
congenital cataract formation. The ﬁrst group consists of structural
proteins in the lens such as lens crystallins, beaded ﬁlaments unique
to lens ﬁber cells, gap junction connexins important for intercellular
communication in the avascular lens, and membrane water trans-
porter aquaporin. The second group consists of transcription factors
e.g. HSF4, MAF, FOXE3, and PITX3 that regulate lens development and
ﬁber cell differentiation [4].
HSF4, despite being a member of the heat shock transcription
factor (HSF) family, plays a role in cell growth and differentiation
instead of stress-induced transcription of genes encoding heat shock
proteins [5,6]. The N-terminal half of HSF4 contains a DNA-binding
domain (DBD) with a ‘winged’ helix–turn–helix motif and hydropho-
bic repeat (HR-A and -B) regions with coiled-coil structures [7]. The
HR-A/B regions mediate HSF4 trimerization. HSF4 trimers bind to the
consensus heat shock element (HSE), made up of inverted repeats of
the 5-bp sequence nGAAn, and to HSE-like sequences [7–9]. There aretwo HSF4 isoforms; HSF4b has the ability to activate transcription but
not HSF4a [10]. Expression of HSF4 is restricted to the brain and lung
[7,10]. HSF4 knockout mice exhibit reduced expression of crystallins
and beaded ﬁlaments in lens and develop cataracts [11–13].
Mutations of human HSF4 have been associated with congenital
cataract [14–18]. Furthermore, two missense mutations were identi-
ﬁed by screening HSF4 in 150 age-related cataract patients [19].
However, how these mutations affect HSF4 function remains unclear.
In this study, we introducedmissensemutations into HSF4b cDNA and
characterized the molecular properties of the mutant proteins.
2. Materials and methods
2.1. In vitro polypeptide synthesis, chemical cross-linking, and
electrophoretic mobility shift assay
Plasmid pcDNA-HSF4b was a derivative of pcDNA3.1(+) contain-
ing HSF4b cDNA [9]. Nucleotide changes were introduced into HSF4b
by site-directed mutagenesis. HSF4b polypeptides were synthesized
in vitro using the TNT T7 Coupled Reticulocyte Lysate System
(Promega). The amounts of synthesized polypeptides were deter-
mined by immunoblot analysis with an anti-HSF4 antibody using
puriﬁed recombinant HSF4b as a reference [9].
For the chemical cross-linking analysis, HSF4b polypeptides
(0.4 ng) in 4 μl of 25 mM Hepes-KOH, pH 7.6, 70 mM NaCl, 2 mM
EDTA, and 5% glycerol were incubated at 37 °C for 20 min, treated
with EGS (ethylene glycol bis-(succinimidylsuccinate)) at room
temperature for 20 min, electrophoresed on a SDS-polyacrylamide
gel, and subjected to immunoblot analysis [9]. The experiments were
performed at least three times with similar results.
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carried out in an 8-μl mixture containing 0.5 ng of HSF4b polypep-
tides, 25 mM Hepes-KOH, pH 7.6, 90 mM NaCl, 2 mM EDTA, 5%
glycerol, 100 ng of poly(dI–dC), and 0.01 ng of 32P-labeled HSE
oligonucleotide at 37 °C for 20 min. The samples were electrophor-
esed and subjected to phosphorimaging [9,20]. The experiments were
performed at least four times with similar results.
2.2. Cell culture and transfection
HeLa cells were cultured in minimum essential medium supple-
mented with 10% fetal bovine serum and 2.5 μg/ml Fungizone
(Invitrogen) at 37 °C in a 5% CO2 atmosphere [9,20]. SRA01/04 cells
were cultured in Dulbecco's modiﬁed Eagle's medium supplemented
with 20% fetal bovine serum, 10 μg/ml gentamycin, and 2.5 μg/ml
Fungizone at 37 °C in a 5% CO2 atmosphere [21]. To express the
HSF4b–VP16 fusion protein in HeLa cells, the activation domain of
herpes simplex virus VP16 (amino acid residues from 413 to 490) was
fused in-frame to the C-terminus of HSF4b in the pcDNA3.1(+) vector
[9]. Transient transfection was performed using HilyMax reagent
(Dojindo Laboratories, Kumamoto, Japan) according to the manufac-
turer's protocol. Expression of HSF4b–VP and HSF4b was veriﬁed by
immunoblot analysis using anti-VP16 and anti-HSF4 antibodies,
respectively [9].
2.3. Luciferase assay
The HSE-SV40p-LUC reporter genes contained 3P-, gap-, and step-
type HSE oligonucleotides inserted upstream of the SV40 promoter
fused to the ﬁreﬂy luciferase gene [9,20]. The luciferase reporter genes
BFSP1-LUC, BFSP2-LUC, CRYAB-LUC, and CRYGC-LUC contained the
following promoter regions respectively: −1044 to −43 of BFSP1,
−998 to −48 of BFSP2, −586 to +3 of CRYAB, and −734 to +3 of
CRYGC (relative to the translation initiation site) [9]. Luciferase assays
were performed as previously described [9,20]. Experiments were
carried out at least eight times, and statistical signiﬁcance was
determined using the Student's t-test.
2.4. Reverse transcription (RT)-PCR analysis
SRA01/04 cells grown in 60-mm dishes were transfected with a
DNA mixture containing 1.1 μg of pcDNA-HSF4b and 7.7 μg of carrier
pcDNA3.1(+) DNA. After 15 h, total RNA was isolated from the cells
using the FastPure RNA Kit (TAKARA BIO). RNA (1.6 μ) was reverse
transcribed with oligo-dT primer (1 μM) using AMV reverse tran-
scriptase (Promega) in a 20-μl reaction mixture for 1 h at 42 °C. Two
microliters of sample was used for PCR (25-μl mixture) with gene-
speciﬁc primers. The PCR products were separated by polyacrylamide
gel electrophoresis and visualized by staining with ethidium bromide.
The amounts of PCR products were compared after normalizing each
sample to the amount of GAPDH PCR product [9,20]. The experiments
were performed at least three times with similar results.
3. Results
3.1. Oligomerization and HSE-binding of HSF4b in vitro
HSF4 mutations associated with congenital cataract formation are
located in the DBD (A20D, R74H, and I87V), linker region (L115P and
R120C), and HR-A (R176P) (Fig. 1A) [14,16,17]. Two mutations
identiﬁed in age-related cataract patients, Q62R and R117H, are
located in the DBD and linker region, respectively [19]. The effects of
these mutations on HSF4b oligomerization were analyzed using in
vitro-synthesized polypeptides (Fig. 1B). Wild-type HSF4b polypep-
tides treated with EGS, a chemical cross-linker, were detected as two
bands on SDS-polyacrylamide gels (Fig. 1C). The faster migrating bandwith a molecular size of 60 kDa was a monomeric form of HSF4b. The
slower migrating band had a molecular size of 180 kDa, which
corresponds to the size of an HSF4b trimer. The Q62R, R74H, I87V,
and R117H mutations did not affect the formation of HSF4b trimers.
However, oligomerization was markedly inhibited in the A20D, L115P,
and R120C mutant proteins and completely inhibited in the R176P
mutant protein under the assay conditions. Therefore, HSF4b oligomer-
ization is modulated by the DBD, linker region, and HR region.
Electrophoretic mobility shift assays were conducted to deter-
mine the HSE-binding ability of HSF4b polypeptides. Probe oligonu-
cleotides were synthetic model HSEs consisting of three inverted
repeats of nGAAn that were either continuous (3P), containing one
(gap), or two (step) skips between three repeats (Fig. 1D). As shown
previously [9], wild-type HSF4b polypeptides were capable of
binding to continuous 3P-type HSE and discontinuous gap- and
step-type HSEs (Fig. 1E). HSF4b containing the A20D mutation
bound to continuous HSE, but not to discontinuous HSEs. In contrast,
HSF4b-Q62R exhibited slightly higher binding afﬁnity for discontin-
uous HSEs than wild-type HSF4b. The I87V and R117H mutations did
not signiﬁcantly affect binding of HSF4b to the three HSE types;
however, the R74H, L115P, R120C, and R176P mutations completely
inhibited binding. These results show that the eight mutant HSF4b
polypeptides exhibit different abilities to oligomerize or bind to
HSEs in vitro.
3.2. Expression of model reporter genes by HSF4b–VP
It has been shown that the DBD of SaccharomycesHSF regulates not
only the DNA-binding ability but also the transactivating ability of the
activation domain [22]. To further analyze the effects of HSF4
mutations on protein–DNA interaction, HSF4b fused to the constitu-
tively active VP16 activation domain was cotransfected with reporter
gene into HeLa cells. HSF4b–VP fusions induce expression of HSE-
SV40p-LUC reporter genes, which containmodel HSEs upstream of the
SV40 promoter-luciferase gene fusion, depending on the DNA-binding
ability, even though the mutations may affect the function of the
HSF4b activation domain [9]. Expression of HSF4b–VP was shown by
immunoblot analysis (Fig. 3A). Cotransfection of wild-type HSF4b–VP
caused a 9.4-, 4.7-, and 4.1-fold increase in luciferase activity of
reporter genes that contained HSE3P, HSEgap, and HSEstep, respec-
tively (Fig. 3B). Consistent with the results of the electrophoretic
mobility shift assays, HSF4b–VP containing the A20D mutation was
capable of inducing expression of reporter gene containing continu-
ous 3P-type HSE, but not discontinuous gap- and step-type HSEs.
Three mutations slightly affected reporter gene activity: the Q62R
mutation appeared to enhance expression of reporter genes contain-
ing discontinuous HSEs, while the I87V and R117H mutations
appeared to inhibit expression of all three reporters. Other mutations
almost completely inhibited the transcription activating ability of
HSF4b–VP. Note that, despite the same amount of plasmid DNA being
used for transfection, protein levels of the transcriptionally active
HSF4b–VP derivatives (WT, Q62R, I87V, and R117H) were reduced
compared with those of the inactive derivatives (A20D, R74H, L115P,
R120C, and R176P) (see Fig. 2A), implying that the expression of
HSF4b–VP is negatively regulated by an unknown feedback mecha-
nism. Whatsoever the reason, the induction of expression by mutant
HSF4b–VP fusions acting on model HSEs varied according to their
DNA-binding abilities.
3.3. Transcription of lens protein genes by HSF4b
To examine the transcriptional activity of HSF4b, wild-type and
mutant proteins were expressed in the human lens epithelial cell line
SRA01/04 (Fig. 3A). The mRNA levels of CRYGC encoding γC-crystallin
were signiﬁcantly increased by wild-type HSF4b, as determined by
RT-PCR (Fig. 3B). HSF4b containing the A20D, R74H, L115P, R120C,
Fig. 1. Characterization of mutant HSF4b polypeptides in vitro. (A) Mutation sites. The DBD, linker, and HR-A/B are shown. The DBD consists of three helices (H1, H2, and H3), four
sheets (S1, S2, S3, and S4), and a wing region. Numbers indicate amino acid positions in HSF4b. (B) SDS-polyacrylamide gel electrophoresis of HSF4b. In vitro-synthesized
polypeptides (0.3 ng) were electrophoresed on a SDS-polyacrylamide gel and subjected to immunoblot analysis with an anti-HSF4 antibody. The positions of molecular mass
markers are shown in kilodaltons (left). (C) Chemical cross-linking of HSF4b. Polypeptides were incubated at 37 °C for 20 min, treated with 0, 0.5, 1.5, and 4.5 mM EGS for 20 min,
and subjected to SDS-polyacrylamide gel electrophoresis and immunoblot analysis. Open and closed arrowheads indicate the positions of HSF4b monomers and trimers,
respectively. (D) Nucleotide sequences of three HSE types. The GAA and inverted TTC sequences are indicated by bold uppercase letters with arrows. (E) Electrophoretic mobility
shift assay of HSF4b–HSE complexes. Polypeptides were incubated with 32P-labeled HSE oligonucleotides of the 3P- (P), gap- (G), and step- (S) types at 37 °C for 20 min. Samples
were subjected to polyacrylamide gel electrophoresis and phosphorimaging. Open and closed circles indicate the positions of free probe DNAs and protein–DNA complexes,
respectively. The binding abilities relative to wild-type HSF4b are shown below each lane.
751Y. Enoki et al. / Biochimica et Biophysica Acta 1802 (2010) 749–753and R176P mutations, but not Q62R, I87V, and R117H, failed to cause
an increase in CRYGCmRNA levels. Similar results were obtained with
reporter gene assays of SRA01/04 cells transfected with HSF4b
derivatives and CRYGC-LUC (luciferase reporter gene fused to the
CRYGC promoter) (Fig. 3C). It is noteworthy that wild-type HSF4b
failed to induce expression of luciferase reporter genes driven by the
γA-, γB-, γD-crystallin promoters (b2.0-fold). Expression of the αB-
crystallin (CRYAB) gene and CRYAB-LUC reporter gene was activated
by HSF4b, but the R74H, L115P, R120C, and R176Pmutations inhibited
the transcription activation ability (Fig. 3B and C). The differential
effects of the A20D mutation on the CRYGC and CRYAB expression
could be due to differences in HSE structure: the CRYGC promoterFig. 2. Transcriptional regulation by HSF4b–VP in HeLa cells. (A) Immunoblot analysis of HSF
derivatives (10 ng). Extracts prepared from the cells were subjected to immunoblot analys
speciﬁc band. (B) Expression of HSE-SV40p-LUC reporter genes by HSF4b–VP. Cells were t
HSF4b–VP-expression plasmid. Data are expressed as fold-induction compared to luciferase
differences (pb0.01).contains an atypical HSE consisting of multiple GAA-like sequences,
whereas the CRYAB promoter contains a 3P-type HSE [9,23]. The BFSP1
and BFSP2 genes encoding beaded ﬁlament structural proteins contain
atypical HSEs consisting of three GAA-like sequences at the promoters
[13]. Wild-type HSF4b induced expression of the BFSP2 gene, BFSP1-
LUC, and BFSP2-LUC, but HSF4b containing the A20D, R74H, L115P,
R120C, and R176P mutations did not (Fig. 3C). Constitutive mRNA
levels of heat shock protein genes encoding HSP27, HSP70, and HSP90
were not signiﬁcantly (b1.2-fold) affected by wild-type HSF4b (data
not shown). These results show that ﬁve out of eight mutant HSF4b
proteins are defective for activating transcription of CRYGC, CRYAB,
BFSP1, or BFSP2 in SRA01/04 cells.4b–VP. Cells were transfected without (indicated by−) or with the indicated HSF4b–VP
is using an anti-VP16 antibody. Position of HSF4b–VP is shown on the right. NS: non-
ransfected with 100 ng of reporter plasmid containing the indicated HSE and 10 ng of
activity in cells transfected with empty expression vector. Asterisks indicate signiﬁcant
Fig. 3. Transcriptional regulation by HSF4b in SRA01/04 cells. (A) Immunoblot analysis of HSF4b. Cells were transfected without (indicated by −) or with the indicated HSF4b
derivatives (200 ng). Extracts prepared from the cells were subjected to immunoblot analysis using an anti-HSF4 antibody. (B) RT-PCR analysis of CRYGC, CRYAB, and BFSP2. Total
RNAwas prepared from cells transfectedwithout (indicated by−) or with the indicated HSF4b derivatives, andwas subjected to RT-PCR analysis of CRYGC, CRYAB, BFSP2, and control
GAPDH. (C) Expression of various reporter genes by HSF4b. Cells were transfected with CRYGC-LUC (400 ng), CRYAB-LUC (200 ng), BFSP1-LUC (500 ng), or BFSP2-LUC (500 ng)
reporter plasmid and 200 ng of HSF4b-expression plasmid. Data are expressed as fold-induction compared to luciferase activity in cells transfected with empty expression vector.
Asterisks indicate signiﬁcant differences (pb0.01).
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In this study, we show that HSF4b is a transcriptional activator of
lens protein genes such as CRYAB, CRYGC, BFSP1, and BFSP2. Five
missense mutations (A20D, R74H, L115P, R120C, and R176P) that
have been associated with congenital cataracts inhibit the transcrip-
tion activation ability of HSF4b. The transcriptional defect of these
mutant proteins is due to a defect in HSE-binding. Mutations in CRYAB,
CRYGC, BFSP1, and BFSP2 cause congenital cataracts [24–28]. A 5-bp
insertion in the CRYGC gene that disrupts the open reading frame is
associated with dominant congenital cataract, suggesting that
reduction of the normal γC-crystallin level or accumulation of the
truncated protein induces cataract [29]. Lenses of mice lacking the
BFSP1 and BFSP2 genes develop opacities with increasing age [30,31].
Therefore, reduced expression of these lens protein genes caused by
mutations in HSF4 could lead to the formation of cataracts. HSF4a
repressor, an alternatively spliced form of HSF4b activator, shares the
DBD and HR-A/B with HSF4b [10], suggesting that mutant proteins
defective in HSE-binding are unable to function properly as
transcriptional activators or repressors.
The R74Hmutation in the third helix of the DBD did not affect HSF4b
trimerization but did inhibit HSE-binding. This is consistent with
observations that the same arginine residue in Kluyveromyces HSF
makes bidentate hydrogen bonds to the guanine base of the nGAAn
sequence [32] and the same residue in SaccharomycesHSF is essential for
HSE-binding [33]. The A20D mutation in the ﬁrst helix of the DBD
markedly inhibited HSF4b oligomerization. The ﬁrst helix of the human
HSF1 DBD is important for oligomerization and HSE-binding [34].
Interestingly, HSF4b-A20D was capable of binding to continuous HSE
butnotdiscontinuousHSEs. The cross-linkingassaywasperformed in the
absence of DNA, while in the DNA-binding experiments protein–DNA
interaction would facilitate protein–protein interaction, and trimeric
HSF4b-A20D bound to continuous HSE. However, efﬁcient oligomeriza-
tion is a prerequisite for binding to discontinuous HSEs in human HSF1
and HSF4b [9,20], suggesting that the A20Dmutant protein will not bind
to discontinuous HSEs. The L115P and R120C mutations in the linkerregion markedly inhibited HSF4b oligomerization and completely
inhibited binding to various HSE types. In Saccharomyces HSF and
human HSF1, mutations in the linker region deregulate oligomerization
[35,36]. It is possible that the L115P and R120C mutations change the
conﬁguration of the DBD and inhibit its DNA-binding ability. The R176
residue is located in the HR-A, and a substitution with a helix-
destabilizing proline residue would disrupt the coiled-coil structure
and result in a loss of its ability to oligomerize and bind to HSE.
The Q62R, I87V, and R117Hmutations hadmarginal effects on lens
protein gene expression by HSF4b in lens epithelial cells (Fig. 3). The
I87V mutation was identiﬁed in an individual with infantile cataract.
This individual's father carried the same mutation and showed a mild
cataract similar to senile cataracts [14]. The Q62R and R117H
mutations were identiﬁed in age-related cataract patients [19].
Although R117 in the linker region is near L115 and R120, L115 and
R120 are highly conserved in mammalian and chicken HSFs while
R117 is not — the same position in chicken HSF2 is histidine [5].
Similarly, I87 in the wing region of the HSF4b DBD is a valine residue
in chicken HSF2 [5]. The Q62 residue in the turn of the helix–turn–
helixmotif changes to basic arginine, and the corresponding residue is
basic lysine in human HSF1 and HSF2 [5]. Therefore, it is likely that the
Q62R, I87V, and R117H mutations do not affect HSF4b function
signiﬁcantly. It should be noted, however, that the Q62R mutation
slightly enhanced binding of HSF4b to discontinuous HSEs (Figs. 1E
and 2B), and that the I87V mutation inhibited binding to step-type
HSE (Fig. 2B). The possibility remains that slight changes in the
transcriptional activity of HSF4 cause age-related cataract. These
mutations could alter expression of other HSF4 target genes. Genetic
and environmental factors could affect the function of these mutant
HSF4 proteins. Hence, studies on HSF4 mutations and the develop-
ment of cataract should be carried out with this in mind.
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